BCAB
Bioatla IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.11M
P/E Ratio
—
EPS
$-41.56
Beta
0.79
52W High
$71.50
52W Low
$3.26
50-Day MA
$5.56
200-Day MA
$21.96
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Bioatla Inc
BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $2.00M |
| Gross Profit (TTM) | $-41.07M |
| EBITDA | $-50.09M |
| Operating Margin | -2520.00% |
| Return on Equity | -814.00% |
| Return on Assets | -134.50% |
| Revenue/Share (TTM) | $1.59 |
| Book Value | $-22.48 |
| Price-to-Book | 2.68 |
| Price-to-Sales (TTM) | 3.06 |
| EV/Revenue | 5.12 |
| EV/EBITDA | 0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 31.60% |
| Shares Outstanding | $1.66M |
| Float | $1.38M |
| % Insiders | 5.63% |
| % Institutions | 23.12% |
Historical Volatility
HV 10-Day
56.16%
HV 20-Day
86.33%
HV 30-Day
110.70%
HV 60-Day
123.76%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026